Search - tctmd.com

Displaying 281 - 300 of 823

Sort: Relevancy | Date

News Daily News

Two RCTs Add Needed Evidence for Thrombectomy in Basilar Occlusion

L.A. McKeown

October 13, 2022

News Opinion CV Team Dispatch

October 2022 News Roundup

L.A. McKeown

October 01, 2022

News Daily News

Statewide Data Spotlight Lasting Impact of Pandemic’s PCI Shortfall in 2020

Shelley Wood

September 28, 2022

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

Shelley Wood

September 22, 2022

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

News Conference News TCT 2022

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

Yael L. Maxwell

September 19, 2022

News Conference News TCT 2022

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Michael O'Riordan

September 19, 2022

News Conference News TCT 2022

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

Shelley Wood

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

News Conference News TCT 2022

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

Todd Neale

September 17, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Todd Neale

August 29, 2022

Presentation ESC 2022

International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches - Chronic Kidney Disease EXTENDed Follow-up: Survival at 5 years of Follow-up

Presenter: Sripal Bangalore

August 29, 2022

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Shelley Wood

August 28, 2022

News Conference News ESC 2022

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

Michael O'Riordan

August 27, 2022

News Conference News ESC 2022

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

L.A. McKeown

August 26, 2022

Advertisement

Two RCTs Add Needed Evidence for Thrombectomy in Basilar Occlusion

October 2022 News Roundup

Statewide Data Spotlight Lasting Impact of Pandemic’s PCI Shortfall in 2020

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

PCSK9 Inhibitors Before PCI Swiftly Lower LDL-C in ACS Patients: EPIC-STEMI

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Ultrasound for Femoral Access? Neutral Results vs Common Sense: UNIVERSAL

SYMPLICITY HTN-3’s Late Surprise: Sustained BP Drop at 3 Years Despite Earlier Miss

Pulmonary Artery Denervation in Idiopathic PAH Ups 6-Minute Walk Test

FLASH: More Data to Support Mechanical Thrombectomy in PE

PROTECTED TAVR: No Less Stroke With Embolic Protection, but Some See Hope

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

New Faces, New Formats, New Tech: What to Expect From TCT 2022

September 2022 News Roundup

Less Death, Major Bleeding With Transradial Access: Meta-analysis

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches - Chronic Kidney Disease EXTENDed Follow-up: Survival at 5 years of Follow-up

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

PCI No Better Than GDMT in Ischemic Cardiomyopathy: REVIVED-BCIS2

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content